logo-loader
viewHeritage Cannabis Holdings Corp.

Heritage Cannabis makes major move by acquiring part of DNA testing company

Heritage Cannabis (CSE:CANN) CEO Clint Sharples sat down with Steve Darling in the Vancouver studio of Proactive Investors to talk about  Heritage buying 30 percent of Endocanna. That company has developed an endocannabinoid DNA test.

Sharples talks about why the company made the move and how this has the potential to fuel growth around the world.

Quick facts: Heritage Cannabis Holdings Corp.

Price: 0.24 CAD

CSE:CANN
Market: CSE
Market Cap: $113.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis Holdings Corp. named herein, including the promotion by the Company of Heritage Cannabis Holdings Corp. in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Ontario's cannabis retail expansion plan gives cannabis stocks...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was 1.4% higher at 116.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF jumped 2.4% at C$9.55, while the OTCQX Cannabis index gained 0.6% to 434 points. Buds today are The Green...

on 12/13/2019

2 min read